These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20963448)

  • 21. [Intensive insulin therapy].
    Landgraf R; Huber RM; Bachmann A; Lohr R
    Dtsch Med Wochenschr; 2008 Apr; 133(17):901-12. PubMed ID: 18415916
    [No Abstract]   [Full Text] [Related]  

  • 22. [Systemic and local allergy to human insulin].
    Wittrup M; Pildal J; Rasmussen AK; Skov BG; Petersen J; Mandrup-Poulsen TR
    Ugeskr Laeger; 2003 May; 165(21):2207-8. PubMed ID: 12820512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin allergy; desensitization with crystalline zinc-insulin and steroid tapering.
    Yokoyama H; Fukumoto S; Koyama H; Emoto M; Kitagawa Y; Nishizawa Y
    Diabetes Res Clin Pract; 2003 Sep; 61(3):161-6. PubMed ID: 12965105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct healthcare costs of patients with type 2 diabetes using long-acting insulin analogues or NPH insulin in a basal insulin-only regimen.
    Gundgaard J; Christensen TE; Thomsen TL
    Prim Care Diabetes; 2010 Oct; 4(3):165-72. PubMed ID: 20452847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
    Yki-Järvinen H
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basal insulins: Pharmacological properties and patient perspectives.
    Abrahamson MJ
    Prim Care Diabetes; 2010 Apr; 4 Suppl 1():S19-23. PubMed ID: 20394887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic allergy to endogenous insulin during therapy with recombinant DNA (rDNA) insulin.
    Alvarez-Thull L; Rosenwasser LJ; Brodie TD
    Ann Allergy Asthma Immunol; 1996 Mar; 76(3):253-6. PubMed ID: 8634879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe anaphylactic reaction to human insulin in a diabetic patient.
    Kaya A; Gungor K; Karakose S
    J Diabetes Complications; 2007; 21(2):124-7. PubMed ID: 17331861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Incidence of severe hypoglycemia in relation to metabolic control and patient knowledge].
    Ratzmann KP; Schimke E
    Med Klin (Munich); 1995 Oct; 90(10):557-61. PubMed ID: 7500918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
    Spoelstra JA; Stolk RP; Heerdink ER; Klungel OH; Erkens JA; Leufkens HG; Grobbee DE
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):121-7. PubMed ID: 12642975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Examination of the treatment of elderly type 2 diabetics--is it possible to change from insulin to oral hypoglycemic agents?].
    Oda K
    Gan To Kagaku Ryoho; 2000 Dec; 27 Suppl 3():711-3. PubMed ID: 11190329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effective switch from premixed to basal-prandial insulin to achieve glycemic goals in type 2 diabetes.
    Lavernia F
    Postgrad Med; 2010 May; 122(3):28-32. PubMed ID: 20463411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Insulin allergy in type II diabetes: rapid desensitization].
    Ruíz Barrera E; Martínez-Cario Cueto S
    Rev Alerg Mex; 1994; 41(1):19-24. PubMed ID: 8087231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Complete resolution of insulin-dependent diabetes mellitus in a patient with autoimmune pancreatitis following treatment with corticosteroids].
    de Mestier L; Dahan M; Hammel P; Hillaire S; Felce M; Penfornis A; Lévy P; Ruszniewski P
    Gastroenterol Clin Biol; 2010 Feb; 34(2):157-9. PubMed ID: 20096519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of insulin glulisine on microvascular blood flow and endothelial function in the postprandial state.
    Hohberg C; Forst T; Larbig M; Safinowski M; Diessel S; Hehenwarter S; Weber MM; Schöndorf T; Pfützner A
    Diabetes Care; 2008 May; 31(5):1021-5. PubMed ID: 18268067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents.
    Ross SA; Zinman B; Campos RV; Strack T;
    Clin Invest Med; 2001 Dec; 24(6):292-8. PubMed ID: 11767232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin allergy resolution following pancreas transplantation alone.
    Oh HK; Provenzano R; Hendrix J; el-Nachef MW
    Clin Transplant; 1998 Dec; 12(6):593-5. PubMed ID: 9850458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allergy to monocomponent porcine and human insulin.
    Mohan V; Shyamsundar R; Ramachandran A; Viswanathan M; Snehalatha C
    J Assoc Physicians India; 1983 Nov; 31(11):721-2. PubMed ID: 6368524
    [No Abstract]   [Full Text] [Related]  

  • 39. Willingness-to-pay for benefits associated with basal insulin treatment of type 2 diabetes.
    Jendle J; Ridderstråle M; Torfvitt O; Ericsson A; Larsen S
    J Med Econ; 2012; 15(2):261-3. PubMed ID: 22142237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anaphylaxis to subcutaneous neutral protamine Hagedorn insulin with simultaneous sensitization to protamine and insulin.
    Blanco C; Castillo R; Quiralte J; Delgado J; García I; de Pablos P; Carrillo T
    Allergy; 1996 Jun; 51(6):421-4. PubMed ID: 8837667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.